SEP 16, 2015 04:57 PM PDT

Aggressive AML

University of Manchester scientists have identified a gene, FOXC1, that, if turned on, can cause more aggressive cancer in a fifth of acute myeloid leukemia (AML) patients, according to a Cancer Research UK study published in the journal Cancer Cell and reported in Drug Discovery & Development
Gene can make acute myeloid leukemia more aggressive.
The FOXC1 gene is normally turned on during embryonic development. It is needed to turn cells into specialized tissues, like the eyes, kidney, brain and bone, but this new research found that in certain patients with AML, a type of blood cancer that affects white blood cells and the bone marrow, this gene was wrongly turned on inside the patient’s cancer cells.

When it is turned on in blood cell tissue, FOXC1 stunts the development of blood cells and stops them from maturing into normal specialized blood cells. This condition causes the cancer to be more aggressive, because young cells are able to replicate more than mature cells. This, in turn, causes cancer cells to grow faster and become more difficult to treat.

About 2,900 people were diagnosed with AML in the UK in 2011. Of that number, around 20 per cent would have had the FOXC1 gene wrongly turned on in their cancer.

According to Dr Tim Somervaille, lead author from the Cancer Research UK Manchester Institute at The University of Manchester, “This is an important finding which helps us understand how acute myeloid leukemia develops and why some cases of AML are more aggressive than others. Here, instead of being faulty or mutated, this normal gene is turned on in the wrong place at the wrong time which makes the cancer grow more rapidly. There are certain situations where this gene is necessary, as in the development of the eye and skeleton before birth. But when it’s switched on in the wrong tissue, it causes more aggressive forms of leukemia.” 

Nell Barrie, senior science communication manager at Cancer Research UK, added, “It’s essential that we continue to research basic biology to further understand how cells become cancerous. In this study, identifying a specific gene behind more aggressive forms of acute myeloid leukemia could give clues for new ways to personalize treatments for select patients. The better we understand the nuts and bolts of each cancer, the sooner we can find new ways to stop it.”
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
JUL 10, 2018
Cancer
JUL 10, 2018
TdT Positive Cells - Not Just for Neoplasms
TdT positive cells are associated with early lymphoid neoplasms but healthy lymphoid precursors can also be positive, especially in pediatric patient lymph nodes....
JUL 13, 2018
Genetics & Genomics
JUL 13, 2018
Detecting Leukemia Before it Starts Growing
Researchers have found ways to identify people who may develop an aggressive type of blood cancer while they are still healthy....
JUL 31, 2018
Cancer
JUL 31, 2018
Protein Regulation of DNA Replication in Cancer Cells - A New Early Target for Broad Therapeutics?
DNA replication is a carefully regulated process in each cell of the body. Researchers are looking at the mechanism of DNA replication and associated proteins as a therapy target in cancer...
AUG 26, 2018
Cancer
AUG 26, 2018
Can antireflux surgery prevent Esophageal cancer?
Heartburn or gastroesophageal reflux disease (GERD) is a widespread health problem affecting 10 to 20% of adults in Western populations. If GERD left untre...
SEP 04, 2018
Cancer
SEP 04, 2018
Glyphosate "herbicides" as a carcinogen
You may have heard of glyphosate as it is a chemical that is approved to be used in herbicides. But did you know that it could lead to cancer!!...
OCT 08, 2018
Immunology
OCT 08, 2018
Natural Killer Cells to Aid in Cancer Therapy
Researchers utilize nanoparticles to stimulate NK cells that induce tumor cells to express PDL1, a protein involved in immune response messaging...
Loading Comments...